HDAC4 and cardiomyopathy: CaMKII is known to have several downstream targets such as histone deacetylase 4 (HDAC4) and nuclear factor of activated T cells (NFAT) in cardiac hypertrophy37, however, its downstream targets in DOX-induced cardiomyopathy have not been revealed yet.